Fracture Recovery for Returning to Duty (Teriparatide STRONG)
Part of paid clinical trials in Columbia, South Carolina.
- Sponsor
- University of South Carolina
- Study ID
- NCT04589819
- Phase
- PHASE4
- Status
- Enrolling By Invitation
Conditions
- Stress Fracture of Tibia or Fibula
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Teriparatide — DRUGTeriparatide, an injectable synthetic parathyroid hormone, will be tested to evaluate its efficacy for decreasing the convalescence after a diaphyseal tibial stress fracture, a specific bone stress injury.
- Placebos — DRUGPlacebo will be a sugar solution of the manufacturer's design.
Study Details
The project goals are to improve combat readiness of U.S. Soldiers and sustain the availability of the military to deploy by, 1) decreasing the number of days not physically ready for duty after diagnosis of a diaphyseal tibial stress fracture, 2) decreasing the need for a physical profile or medical discharge board after bone stress injury, and 3) decreasing the recurrence rates of bone stress injuries.
Key Dates
- Start date
- Dec 8, 2022
- Status verified
- Feb 2023
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2026
Study Design
- Enrollment
- 183 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: TeriparatideStudy participants will be randomized into either the study medication arm or a placebo arm. The study medication Forteo (teriparatide \[rDNA origin\] injection) (El-Lilly, Indiana, USA), will be administered via an blinded injection pen in the abdominal wall or thigh as described in the product guide. Subjects in the teriparatide arm will receive a 20mg dose of the medication daily via self-injection.
- Placebo Comparator: PlaceboThe placebo will be administered in a replica, blinded, injection pen in the same fashion. The study participant will self-administer the medication after being given a teaching session on medication administration by the study nurse.
Primary Outcome Measure
Time from diagnosis to full return to activity [ Time Frame: 3 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Fort Jackson | Columbia | South Carolina | 29207 | - |
Find similar trials in Columbia, SC
By research site